Week30, 2024
1. Seasonal influenza activity remains low, with 0.7% of respiratory specimens testing positive for influenza nationally.
2. Of the positive specimens, clinical labs reported 89.1% Influenza A and 10.9% Influenza B, while public health labs reported 93.2% Influenza A and 6.8% Influenza B.
3. Weekly outpatient visits for respiratory illness were 1.5%, below the baseline, with stable trends across all U.S. regions.
4. The weekly influenza-associated hospitalization rate was 0.1 per 100,000, significantly lower than the season peak of 9.0 per 100,000.
5. Influenza-associated deaths accounted for 0.03%, with 1 new pediatric death this week, totaling 188 pediatric deaths for the season.
6. Multiple respiratory viruses, including COVID-19, influenza, and RSV, are co-circulating, though no new cases of novel influenza A were reported this week.
7. There is ongoing antigenic characterization of influenza viruses, with most tested strains well-matched to the vaccine.
8. Resistance to antiviral medications remains low, with only a few variants showing reduced susceptibility.
9. No jurisdictions reported moderate or high ILI activity, and most regions reported minimal flu activity.
10. Flu activity remains low, but vigilance is necessary due to the co-circulation of other respiratory pathogens and ongoing H5N1 avian outbreaks.